Graphical Abstract Highlights d Self-inactivating rabies virus (SiR) provides life-long access to neural networks d SiR has no adverse effects on neuronal physiology and network computations d SiR allows open-ended Ca 2+ imaging of network activity and functional intervention d SiR allows generation of circuit-specific knockouts SUMMARY
INTRODUCTION
Network dynamics are thought to be the substrate of brain information processing and of mental representations (Buzsá ki and Freeman, 2015; McIntosh, 2000) . From a clinical perspective, network-wide dysfunction is also beginning to be recognized as the culprit behind a number of psychiatric (Rubinov and Bullmore, 2013) and neurodegenerative disorders (Roselli and Caroni, 2012) . Consequently, major efforts have been made in the development of methods to unravel the organization of neural networks both in animal models and humans (Callaway, 2008; Cardona et al., 2010; Livet et al., 2007; Osten and Margrie, 2013; van den Heuvel et al., 2016) . However, defining circuit architecture is only the first step toward understanding the physical implementation of information processing in the brain. Information about circuit topology, namely the relationships among neurons within a connected network, should also be used to gain functional and genetic access to topologically defined network elements, as this would allow probing their functional role in neural computation and behavior.
The recent development of G-deleted rabies virus (DG-rabies) (Mebatsion et al., 1996; Wickersham et al., 2007b) provided the first non-electron microscopy (EM)-based method aimed at revealing network synaptic topology upstream of defined nodes (Miyamichi et al., 2011; Stepien et al., 2010; Tripodi et al., 2011; Wickersham et al., 2007b) . Despite the transformative role of DG-rabies-based approaches in the anatomical investigation of neuronal circuits, their use to manipulate the functional properties of neural networks in vivo remains limited. The main reason of this limitation relates to the cytotoxic effects of the rabies virus. The DG-rabies is a replication-competent virus that eventually leads to neuronal death (Wickersham et al., 2007a) . The temporal window for optical imaging and functional interventions enabled by DG-rabies in functionally unaffected circuits is thus limited to 5-17 days from infection (Namburi et al., 2015; Tian et al., 2016; Wertz et al., 2015) .
We reasoned that, in order to circumvent this limitation, it would be sufficient to transcriptionally silence the virus shortly after the primary infection. Transcriptional silencing of DNA-based viruses, such as adeno-associated viruses (AAVs), is generally achieved by using conditional recombinant cassettes that invert the viral genes of interest upon recombination (Atasoy et al., 2008) . However, strategies to conditionally manipulate the expression of RNA-based viruses, such as rabies, are currently lacking. Given the unique coupled nature of transcription and replication of the rabies virus and their dependence on virally encoded proteins (Finke and Conzelmann, 2005) , we hypothesized that the conditional modulation of viral protein stability, as opposed to viral genome recombination, could act as an ON-OFF switch with which to direct the viral transcription-replication cycle. To this aim, we engineered the rabies genome so that selected viral proteins could be reversibly targeted to the proteasome using a conditionally cleavable proteasome-targeting domain. This gave origin to a self-inactivating DG-rabies (SiR) that switches OFF following the primary infection, thereby preventing cytotoxicity while providing permanent genetic access to the mapped neural elements via a CRE/FLP-mediated recombination event triggered soon after the infection. We show that SiR-infected neurons retain unaltered physiological properties, functional connectivity, and normal synaptic function several months following the primary infection and, likely, for the entire life of the animal. Furthermore, we used SiR to perform in vivo 2-photon calcium imaging of V1 neurons projecting to V2, showing that computational properties of V1 neurons, such as their orientation tuning, remain intact after SiR infection. The development of the SiR virus gives, for the first time, permanent functional and genetic access to neural networks with no adverse effects on neural physiology, circuit function, and circuit-dependent computations.
RESULTS

Conditional Control on the Rabies Life Cycle
Given that both transcription and replication of the rabies virus depend on virally encoded proteins, we hypothesized that conditional modulation of viral protein stability may act as a switch on the viral transcription-replication cycle. To achieve such a modulation, we fused a PEST proteasome-targeting domain to each and every protein of the DG-rabies virus (individually or in combinations) in order to direct their proteasomal degradation ( Figure 1A ; full list of constructs in Table S1 ). To implement a level of conditional control on viral protein stability, the Tobacco Etch Virus cleavage site (TEVs) was interposed between the particular viral protein and the proteasome-targeting domain. The tobacco etch virus protease (TEVp) selectively cleaves the TEVs linker, separating the viral proteins from the proteasome-targeting domain, sparing them from degradation ( Figures 1A and 1B ). The binary system composed by TEVp and TEVs should provide a form of exogenous control on the extent and temporal window of viral protein degradation during viral production and, potentially, in vivo. Namely, the virus should be able to transcribe and replicate only when TEVp is present, giving origin to a system in which viral transcription and replication are constitutively OFF unless TEVp is provided. (C-H) Quantification of amplification efficiency for all recombinant rabies constructs (magenta) and control rabies (cyan) as a percentage of infected cells (mCherry positive) (mean ± SD; dashed line shows 50% threshold level used in the screening). M PEST (C), L PEST (D), P PEST (E), N PEST (F), P/L PEST (G), and N/P/L PEST (H) are shown. (I-K) Quantification of amplification efficiency in HEK-TGG (cyan, +TEVp) and HEK-GG (magenta, ÀTEVp). x axis, days post-transfection (p.t.); y axis, amplification efficiency. CTR (I), L PEST (J), and N PEST (K) are shown. See also Figures S1, S2, S3, and Table S1 .
We screened the suitability to viral production and TEVp dependence of six viral constructs, in which each viral protein was targeted to the proteasome alone or in combination (Figures 1C-1K; Table S1 ). To this aim, we generated a stable cell line expressing TEVp and the spike glycoprotein ( Figures 1A and 1B) . Surprisingly, the destabilization of the viral proteins M, P, N/P, and N/P/L led to a virus unable to efficiently spread even in presence of the protease. In contrast, the virus with proteasome-targeted L protein did amplify both in presence ( Figure 1D ) and absence ( Figure 1J ) of the TEV protease, indicating that the partial destabilization of the L protein by the degradation domain is insufficient to impair the viral replication machinery. The virus in which the N protein alone was destabilized showed the desired conditional control: failure to amplify in absence of TEVp and successful amplification in TEVp-expressing cells (at 18 days post transfection +TEVp 80% ± 4%, ÀTEVp 2% ± 0.2% of infected cells, p = 3 3 10 À3 , two-tailed two-sample Student's t test, Figure 1K ). This indicates that N is the sole viral protein whose conditional destabilization, in our design, is sufficient to reversibly suppress the viral transcription-replication cycle. We confirmed that the conditional inactivation of the N-tagged DG-rabies is a proteasome-dependent process by amplifying the virus in absence of TEVp but in presence of the proteasome inhibitor MG-132 ( Figure S1A ). Indeed, the amplification rate of the N-tagged DG-rabies virus significantly increases, in a dose-dependent manner, following the administration of the proteasome inhibitor MG-132 (at 12 days post transfection 0 nM MG-132, 0.1% ± 0.1%; 250 nM MG-132, 13% ± 5% of infected cells, p = 0.04, two-tailed two-sample Student's t test, Figure S1B ). After a further round of improvement on the viral cassette design (Figures S2 and S3; STAR Methods), we were able to produce a SiR with the desired TEVp-dependent ON/ OFF kinetics constituted by an NPEST-rabies-mCherry cassette containing a TEVp-cleavable linker between N and the PEST sequence.
Permanent Genetic Access to Neural Circuits with SiR
In order to experimentally assess the in vivo cytotoxicity of the newly generated SiR, we added a CRE recombinase and a destabilized mCherry (SiR CRE-mCherry , Figure 2B ) to the SiR genome. We then tested SiR transcription-replication kinetics and cytotoxicity in vivo by injecting SiR CRE-mCherry in the CA1 pyramidal layer of Rosa-LoxP-STOP-LoxP-YFP mice ( Figure 2B ). The transient expression of the CRE recombinase driven by the SiR should be adequate to ensure a permanent recombination of the Rosa locus and consequent YFP expression even after a complete transcriptional shut down of the virus (Figure 2A ). At the same time, the destabilized mCherry marks the presence of active virus with high temporal resolution. Indeed, while at 3 days post infection (p.i.) only the virally encoded mCherry can be detected (Figures S4C-S4C 000 and S4F), by 6 days p.i. the virally encoded CRE has induced recombination of the conditional mouse reporter cassette, triggering the expression of YFP in all infected neurons (Figures S4D-S4D 000 and S4F 0 ). In order to exclude any SiR-induced cytotoxicity, we monitored the survival of SiR CRE-mCherry -infected CA1 pyramidal neurons over a 6-month period. By 3 weeks p.i., the SiR had completely shut down (98% ± 2% YFP ON mCherry OFF , Figures 2D-2D 000 and 2G) and, more importantly, no significant neuronal loss was observed during the 6-month period following SiR infection (one-way ANOVA, F = 0.12, p = 0.97, Figures 2F-2F 000 and 2G). This is in striking contrast with what is observed after canonical DG-rabies infection, in which the majority of infected neurons in the hippocampus die within 2 weeks from the primary infection ( Figures  S5A-S5C ). We further confirmed the absence of SiR-induced cytotoxic effects in vivo by assessing the level of caspase-3 activation (cCaspase3) at 1 and 2 weeks following SiR infection and comparing it to that elicited in mock-injected controls. The results indicate no significant differences between SiR and mock-injected conditions in the levels of caspase-3 activation (one-way ANOVA, F = 0.11, p = 0.7, Figures S5F-S5G 000 and S5H). Monitoring the in vivo viral RNA genomic titer during the course of the infection also shows that SiR completely disappears (at a genomic level) from the infected neurons by 2 weeks p.i. ( 
SiR Pharmacological Reactivation In Vivo
Experiments in vitro indicate that modulation of viral stability by conditional proteasome degradation is sufficient to modulate the viral transcription-replication cycle. In order to assess whether conditional control over viral protein degradation can be achieved in vivo, we designed an AAV virus to express TEVp under a doxycycline-inducible promoter (AAV TRE::TEVp , Figure 3A ) (Shockett and Schatz, 1996) . This should provide pharmacological control on the viral transcription-replication cycle by doxycycline-mediated release of viral N protein from targeted proteasomal degradation.
To address if and at what stage post infection SiR can be reactivated by doxycycline administration, we injected CA1 neurons in the hippocampus with AAV TRE::TEVp followed by the SiR CRE-mCherry injection 1 week after. Doxycycline (100 mg/kg) was then administered by oral gavage for 2 days at two different time points, after 1 or 2 weeks post SiR infection ( Figure 3B ). In agreement with the viral RNA profile analysis, administration of doxycycline at 1 week post SiR infection, when the virus is still transcriptionally active, significantly increases the percentage of YFP ON mCherry ON neurons (YFP ON -mCherry ON Àdoxy 22% ± 3%, +doxy 38% ± 2%, p = 0.02, Figures 3C-3D 00 and 3G). Moreover, we observed no effect by administering doxycycline 2 weeks post SiR infection (YFP ON -mCherry ON Àdoxy 1% ± 1%, +doxy 1% ± 1%, p = 0.2, Figures 3E-3G ). These results indicate that the transcriptional activity of the virus, as reflected by mCherry expression, can be sustained in vivo if doxycycline is administered in an early time window before the complete disappearance of the virus.
SiR Transsynaptic Spreading Capabilities
For its use in long-term functional investigations of neural networks, it is key that the SiR retains the ability to spread transsynaptically. Therefore, we assessed the spreading capabilities of SiR and compared it to the canonical B19 DG-rabies in both cortical and subcortical circuits. In order to test this, we first injected the nucleus accumbens (NAc) bilaterally with an AAV expressing TVA and the newly developed optimized rabies glycoprotein (oG) ( Figure 4A ), which has been shown to enhance rabies virus spreading (Kim et al., 2016) . The expression of TVA permits selective infection of the starting cells in the NAc by an EnvA pseudotyped SiR, while the expression of oG allows its transsynaptic retrograde spread (Kim et al., 2016; Wickersham et al., 2007b) . Then, we re-targeted the NAc in the two hemispheres with either SiR or DG-rabies EnvA-pseudotyped viruses. In agreement with the known connectivity of this area (Russo and Nestler, 2013) , we identified transsynaptically labeled neurons in various cortical and subcortical regions, including the basolateral amygdala (BLA) and ventral tegmental area (VTA). We focused on these two areas to quantify spreading efficiency. At 1 week p.i., we observed no significant difference in the spreading capabilities between SiR and the canonical B19 DG-rabies ( Figures 4A, 4B , 4D, 4D 0 , 4F, 4F 0 , and 4I; one-way ANOVA, F = 0.03, p = 0.96), indicating that the self-inactivating nature of the SiR does not affect its ability to spread efficiently. Moreover, as expected, by 3 weeks p.i., we observed a decrease in the number of transsynaptically labeled neurons upon B19 DG-rabies infection due to neuronal loss, while no changes upon SiR infection were detected (Figures 4C, 4E, 4E 0 , and 4G-4H; B19 DG-rabies, one-way ANOVA, F = 43, p = 6 3 10 À5 ; SiR, one-way ANOVA, F = 0.03, p = 0.96).
Furthermore, we tested the transsynaptic spreading ability of SiR also in hippocampal circuits by targeting the pyramidal layer of CA1 of Rosa-LoxP-STOP-LoxP-YFP mice. As expected, we identified neurons labeled by the SiR in the pyramidal layer of CA3 (Figures S6A and S6A 00 ), indicating specific transsynaptic spreading. Presynaptic neurons were also identified in the lateral entorhinal cortex (LEC) as evidenced by YFP expression ( Figure S6A spreading was compatible with long-term survival of the synaptically connected neurons.
The use of CRE recombinase in the SiR limits its application in combination with available mouse CRE lines. This is a limiting factor when trying to initiate the transsynaptic spreading from genetically defined neuronal populations. To overcome this shortcoming, we generated an SiR encoding for a FLP recombinase and tested its efficiency. We specifically targeted CA1 pyramidal neurons by injecting a CRE-dependent AAV expressing TVA and oG (AAV-FLEX TVA-oG ) in CA1 of VGlut2::CRE mice, in which the CRE recombinase is expressed in excitatory neurons ( Figure S6C ). At the same time, we targeted the presynaptic area CA3 with a FLP-dependent AAV encoding a nuclear-tagged GFP (AAV-FRT nucGFP ) ( Figure S6C ). The AAV-FRT nucGFP virus drives GFP expression following a FLP-dependent recombination event. We then injected SiR FLP (EnvA) in CA1 initiating the transsynaptic spreading selectively from TVA-expressing excitatory neurons (Figures S6C and S6C 0 ). Transsynaptically labeled neurons can be observed in the CA3 presynaptic target area (Figure S6C 00 ), proving the viability of the approach.
In order to confirm the general validity of this method, we decided to use a distinct transgenic line to start the transsynaptic spreading also from inhibitory neurons. We first injected AAV-FLEX TVA-oG in the NAc of VGAT::CRE mice to selectively target the inhibitory neuronal population in this area. We then injected the AAV-FRT nucGFP in a known presynaptic area, the BLA ( Figure S6D ). Then, we specifically targeted TVA-positive neurons with SiR FLP (EnvA), thus initiating the transsynaptic spread selectively from NAc inhibitory neurons ( Figures S6D and S6D 0 ). This led to efficient FLP-dependent transsynaptic labeling of neurons in BLA (Figure S6D 00 ). Overall, these results confirm the efficiency of a CRE-and FLP-dependent combinatorial approach based on the use of SiR FLP in conjunction with available CRE mouse lines, expanding the range of use of the SiR.
Use of SiR as Retrograde Non-transsynaptic Tracer
Given the paucity of highly efficient and selective axonal retrograde viral tracers, we took advantage of the high affinity of the rabies virus for axon terminals and assessed whether the SiR can be used also as retrograde intraneuronal (non-transsynaptic) tracer. To this aim, we pseudotyped the SiR with oG (Kim et al., 2016) . Using this approach, we mapped the synaptic inputs to the VTA with SiR (oG) comparing its non-transsynaptic retrograde spreading efficiency with one of the most efficient retrograde viruses available to date, the rAAV2-retro (Tervo et al., 2016) . We focused our analysis on three known presynaptic areas to VTA: the medial prefrontal cortex (mPFC), the NAc, and the lateral hypothalamus (LH) ( Figure 4J ) (Watabe-Uchida et al., 2012) . Overall, spreading efficiency is broadly comparable between SiR and rAAV2-retro ( Figure 4N ). However, SiR was more efficient in labeling subcortical structures such as LH and NAc (LH, p = 0.18; NAc, p = 0.03; Figures 4L-4L 00 , 4M-4M 00 , and 4N), with more than one order of magnitude of difference in the case of the NAc to VTA circuit. On the other hand, the (legend continued on next page) rAAV2-retro turned out to be more efficient in labeling cortical targets such as the mPFC (p = 0.05, Figures 4K-4K 00 and 4N).
Altogether, these data indicate that SiR also functions as a highly effective retrograde axonal (non-transsynaptic) tracer.
Unaffected Neuronal and Synaptic Functions on SiR Infection
While the absence of cytotoxicity and the maintenance of transsynaptic spreading ability of the SiR is encouraging for its use in the functional manipulation of neural networks, we also wanted to make sure that SiR has no long-term effects on neuronal physiology. In order to do so, we injected SiR CRE in the pyramidal layer of CA1 in Rosa-LoxP-STOP-LoxP-tdTomato mice. We then compared the electrophysiological properties of infected and non-infected neurons at 1 week and 5 months following SiR infection. Tomato ON neurons in CA1 were recorded in whole-cell patch-clamp mode. All pyramidal CA1 neurons recorded showed regular spiking profiles ( Figure 5A ) with no significant difference among all tested conditions and time points in the input resistance, resting membrane potential, spike threshold, action potential amplitude and half-width, and instantaneous firing frequency (Figures 5B-5F; Table S2 ). Furthermore, when SiR CRE was injected in Rosa-LoxP-STOP-LoxP-ChR2YFP mice, ChR2 was successfully expressed in transduced neurons ( Figures 5G-5J ). Brief light pulses (0.5-2 ms) lead to ChR2 direct activation in transduced neurons and triggering of action potentials with short latency (5.4 ± 0.6 ms spike-peak latency, . Infected neurons could be activated at various frequencies with similar reliability at both 1 week and 2 months p.i. ( Figure 5I ). A key finding was that light activation of SiR CRE -infected neurons elicited DNQX-sensitive excitatory postsynaptic potentials (EPSPs) (latency 6.8 ± 0.4 ms) in noninfected neurons at 2 months p.i. (Figure 5J ), indicating persistence of functional connectivity and no adverse effects on synaptic function.
Investigating Network Dynamics with SiR
The absence of cytotoxicity and unaltered electrophysiological responses support the use of SiR for long-term circuit manipulations. The presence of functional connectivity between SiR-infected neurons and no adverse effects on synaptic properties also indicate that network function is likely to be preserved following SiR infection. In order to test whether network-dependent computations are also preserved and whether SiR can be used to monitor neural activity in vivo, we looked at a prototypical example of network-dependent computation, orientation tuning in visual cortex. We first targeted V1 neurons projecting to V2 (V1 > V2 ) by injecting oG pseudotyped SiR CRE in the V2 area of Rosa-LoxP-STOP-LoxP-tdTomato mice. At the same time, we injected an AAV GCaMP6s in the ipsilateral V1 ( Figure 6A ). Retrograde spreading of SiR CRE from V2 induced recombination of the Rosa locus permanently labeling V1 > V2 neurons (Figures 6B-6B 00 ; Movie S1). We then monitored the Ca 2+ dynamics of SiR-infected V1 > V2 neurons in vivo 4 weeks p.i., under a twophoton microscope, while anesthetized animals were exposed to moving gratings of different orientations across the visual field ( Figure 6C ) (Benucci et al., 2009) . Infected V1 > V2 neurons showed significant increases in fluorescence at particular grating orientations resulting in a cellular tuning curve showing direction or orientation selectivity ( Figures 6G and 6H) . Notably, recorded Ca 2+ responses, as well as the percentage of active neurons, were similar between SiR-traced neurons (GCaMP6s ON -tdTomato ON ) and neighboring non-SiR V1 neurons (GCaMP6s ON -tdTomato OFF ) ( Figures 6E and 6F ). Furthermore, to exclude the possibility of long-term deleterious effects on circuit function following SiR infection, we repeated functional imaging experiments at 2 and 4 months p.i. ( Figure S7 ). In both cases, we found no significant difference in percentage of active neurons or stimulus-driven responses between GCaMP6s ON -tdTomato ON and GCaMP6s ON -tdTomato OFF neurons (Figures S7F-S7H 00 ). These data indicate that SiR-traced networks preserve unaltered computational properties and that SiR can be used in combination with GCaMP6s to monitor the Ca 2+ dynamic with no upper bounds to the temporal window for the optical investigation.
DISCUSSION
The development of monosynaptically restricted rabies viruses has had a transformative effect on the study of neural circuits (Miyamichi et al., 2011; Stepien et al., 2010; Tripodi et al., 2011; Wickersham et al., 2007b) . Until now, however, the cellular cytotoxicity that accompanies rabies virus infection effectively limited the temporal window for its use for the functional interrogation of neural circuits. The induced cytotoxicity is linked to the transcriptional activity of the virus. Replicative and transcriptionally competent rabies viruses hijack the cellular translational machinery to sustain their replication at the expense of endogenous cellular translation (Komarova et al., 2007) . This affects cellular function, cellular transcriptional profile, and eventually, neuronal function and survival. Therefore, any replicative competent rabies virus, including less cytotoxic strains (Reardon et al., 2016) , will eventually compromise cellular physiology within a particular time frame. In order to gain life-long genetic and functional access to network elements defined topologically by rabies-dependent gene expression and in the absence of any adverse cytotoxic effects, we developed a SiR that transcriptionally disappears from infected (I) Efficiency of spreading at 1 week p.i. as number of inputs normalized to number of starting cells, and of SiR and DG-rabies in BLA and VTA (SiR = 1, mean ± SEM, n = 3 animals). (J) Scheme of retrograde intraneuronal spreading from VTA. (K-M 00 ) Retrogradely labeled neurons with SiR and rAAV2-retro (SiR, magenta; rAAV2-retro, cyan) in medial prefrontal cortex (mPFC) (K-K 00 ), lateral hypothalamus (LH) (L-L 00 ), and NAc (M-M 00 ). (N) Number of SiR-and rAAV2-retro-infected neurons in NAc, LH, and PFC (mean ± SEM, n = 3 animals) Scale bars, 1,000 mm (K-M); 50 mm (K 0 , K 00 , L 0 , L 00 , M 0 , and M 00 ). See also Figure S6. neurons shortly after the primary infection but has sufficient transcriptional activity in those early stages to genetically tag infected neurons for the long-term.
In line with the complete transcriptional silencing of the virus, we observed no changes in the electrophysiological signature between infected and uninfected neurons 1 week post infection, when viral transcription is dampened but still present, and 5 months after infection, a time point at which the SiR has switched OFF but that is well beyond the survival window of neurons infected with canonical B19 DG-rabies (Wickersham et al., 2007a) . Moreover, we showed that SiR virus can be employed in long-term studies using optogenetics with no reduction in the reliability of optical stimulation and, most importantly, maintaining the synaptic function and integrity that is key for physiological and behavioral studies. By using SiR to monitor calcium dynamics in vivo, we show that circuit-dependent responses of Table S2. infected neurons, such as visual tuning to moving stimuli, remain unaffected after viral infection.
The unique features of the SiR make it the ideal tool for longterm functional and genetic modification of neural networks. Such interventions may include the functional manipulation of neural circuits with light-activated opsins or chemically gated channels as well as the study of long-term network activity using genetically encoded calcium indicators (Emiliani et al., 2015; Luo et al., 2008; Packer et al., 2013 Packer et al., , 2015 ( Figure 7A ). With the canonical B19 DG-rabies, the safe temporal window that ensures near-physiological neuronal responses and minimal neuronal loss has been reported to be between 5-15 days from the infection, with slight differences between reports, possibly reflecting different sensitivity of distinct neuronal populations (Kiritani et al., 2012; Namburi et al., 2015; Tian et al., 2016; Wertz et al., 2015) . The use of the recently introduced DG-rabies strain variant CVS-N2c DG has been reported to push the useful temporal window for imaging further up to 17 days post infection (Reardon et al., 2016) . With SiR, traced neurons remain healthy indefinitely, and there are no upper bounds to the temporal window for the optical or functional investigation of neural circuits in physiological conditions except for those imposed by the imaging approach itself and the expressed transgene of choice.
SiR also makes it possible to knockout genes of interest in a circuit-specific manner via genomic recombination of a conditional cassette, for the first time without any associated neuronal loss or temporal constraints ( Figure 7B ). In addition, the uniquely transient transcriptional nature of SiR combined with permanent CRE-dependent tracing offers the possibility to trace recurrently the circuit upstream of a defined entry node over time, leaving a permanent snapshot of the network topology at each iteration ( Figure 7C ). This feature may be exploited to follow circuit remodeling after physiological or pathological structural plasticity, such as during development, upon learning or following traumatic brain injuries.
Switching OFF viral transcription is not only instrumental to abolish cell death and preserve neuronal function, but it also eliminates the problem of the rabies-mediated inhibitory effect on the cellular translational machinery (Komarova et al., 2007) . Moreover, a further advantage of the self-inactivating nature of the virus is that it may allow for lowering the biosafety requirement for its production. We show that upon infection in vivo, there are no detectable viral particles in the injected brain tissue after 2 weeks from the primary infection, which may lead to downgrading SiR safety level.
One caveat to consider when using SiR is that, while our design produces a neurotropic virus that has no adverse effects on neuronal function and survival, this is at the cost of switching OFF its own transcription. Therefore, the delivery of transgenes of interest must be achieved in a combinatorial manner by making use either of floxed viral cassettes (i.e., AAVs) or of transgenic conditional mouse lines. Notably, we successfully implemented both strategies in this study.
Our findings establish SiR as a tool that provides functional and genetic access to traced network elements safely in vivo for the lifetime of the animal, with no cytotoxic effects, no changes in the intrinsic electrophysiological properties of the infected neurons, and no adverse effects on network function Figure S7 and Movie S1. and network-dependent computations, opening new horizons in the functional investigation of neural circuits.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal strains
Male mice aged between 8 and 12 weeks from of the following lines were used: C57BL/6 wild-type (WT), Rosa-LoxP-STOP-LoxP-tdTomato (Jackson: Gt(ROSA)26Sortm14(CAG tdTomato), Rosa-LoxP-STOP-LoxP-YFP (Jackson: Gt(ROSA)26Sor < tm1(EYFP) Cos > ), Rosa-LoxP-STOP-LoxP-ChR2-YFP (Jackson: B6.Cg-Gt(ROSA)26Sortm32(CAG-COP4*H134R/EYFP)Hze/J), VGAT::CRE (Jackson: Slc32a1tm2(cre)Lowl), VGlut2::CRE (Jackson: Slc17a6tm2(cre)Lowl). All transgenic mice were isogenic in a C57BL/6 background, maintained in pathogen and opportunistic agents-free conditions and monitored quarterly. All procedures were conducted in accordance with the UK Animals (Scientific procedures) Act 1986 and European Community Council Directive on Animal Care. Animals were group-housed in a 12 hr light/dark cycle with food and water ad libitum.
Cell lines
HEK293T cells and BHK-21 were purchased from ATTC. All cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM, GIBCO) supplemented with 10% fetal bovine serum (FBS, GIBCO) and 1% Penicillin/Streptomycin (GIBCO) unless otherwise stated. HEK293T packaging cells expressing Rabies glycoprotein (HEK-GG) were generated by lentivirus infection with Lenti-H2B GFP-2A-GlySAD (Table S1 ) and after 3 passages GFP expressing cells were selected by fluorescent activated cell sorting (FACS). HEK293T packaging cells expressing Rabies glycoprotein and TEV protease (HEK-TGG) were generated from HEK-GG by lentivirus infection with Lenti-puro-2A-TEVp and selected, after 3 passages, with 1 mg/mL of puromycin added to the media for 1 week. BHK-21 packaging cells for pseudotyping Rabies virus with optimized G (BHK-TGoG) were generated with the same procedure as the HEK-TGG by the infection first with Lenti-H2B GFP-2A-oG and subsequently with Lenti-puro-2A-TEVp. BHK packaging cells for pseudotyping Rabies virus with EnvA receptor (BHK-T-EnvA) were obtained infecting BHK-EnvA with Lenti-puro-2A-TEVp and selecting with puromycin.
METHOD DETAILS
First generation DG-N PEST Rabies. In vitro and in vivo tests of cytotoxicity In order to obtain conditional regulation of viral protein stability, in addition to the C-Terminal PEST domain (see main text), a SPLIT-TEVp cassette (Gray et al., 2010) was cloned in the DG-Rabies genome. A tag (myc, FLAG or V5) was also fused to the N-terminal of each viral protein. The SPLIT-TEVp dimeric protease is only active in presence of rapamycin and could potentially provide a tool for the exogenous regulation of viral protein stability during production and in vivo. We first tested the capability of the SPLIT-TEVp expressed by plasmid to cleave a TEVp activity reporter in HEK293T cells ( Figure S2B ), then we tested the ability of the virally expressed cassette to cleave the TEVp activity reporter ( Figure S2C) .
In order to probe the effect of protein destabilization on neuronal survival, we infected human Embryonic Stem cells (hESCs) derived neurons with DG-N PEST Rabies SPLIT-TEVp-mCherry . We performed a longitudinal study of the survival of infected neurons and compared survival rate to a control DG-Rabies. Neurons were infected and imaged longitudinally at 4, 10 and 16 days to evaluate the cell death ( Figures S3A-S3C 00 ). Lentivirus expressing GFP was used to normalize infection rates in order to account for cell death due to the prolonged manipulation and repeated over-night imaging sessions. Only 26% ± 4% of control DG-Rabies infected neurons were still detectable at 16 days post-infection (N = 3, n = 781 for each condition; Figures S3C-S3C 00 and S3D) . On the contrary, the DG-N PEST Rabies SPLIT-TEVp-mCherry virus showed no significant cell loss after 16 days (94% ± 6%, N = 3, n = 917 for each condition, Figures S3B-S3B 00 and S3D ) and a significant increase in cell survival compared to DG-Rabies control (p = 3.2x10 À5 ; paired twotailed Student's t test).
To understand if the reduced cytotoxicity of DG-N PEST Rabies SPLIT-TEVp-mCherry is associated with a reduction of the viral transcription, we monitored the intensity of the reporter expressed in neurons infected with the control DG-Rabies and the DG-N PEST Rabies S-PLIT-TEVp-mCherry viruses which share the same expression cassette ( Figure S3E) . Over time the mean mCherry signal of DG-N PEST Rabies SPLIT-TEVp-mCherry infected cells resulted to be significantly lower than controls (mCherry intensity at 10 days, DG-Rabies 138% ± 3%, DG-N PEST Rabies SPLIT-TEVp-mCherry 87% ± 7%, p = 0.01; N = 3, n = 584 for each condition; paired two-tailed Student's t test).
We then tested the performance of the DG-N PEST Rabies SPLIT-TEVp-mCherry virus in vivo. We replaced the mCherry gene in the DG-N PEST Rabies SPLIT-TEVp-mCherry virus with the CRE recombinase (DG-N PEST Rabies SPLIT-TEVp-CRE ). This ensures that infected neurons can be permanently labeled after a complete transcriptional shut down of the virus, allowing for the discrimination between viral silencing and cell death. We injected DG-N PEST Rabies SPLIT-TEVp-CRE in CA1 of Rosa-LoxP-STOP-LoxP-tdTomato reporter mouse line in CA1 in the hippocampus ( Figure S3F ). We observed a significant increase in neuronal survival upon DG-N PEST Rabies SPLIT-TEVp-CRE infection compared to that observed upon infection with control DG Rabies (25% ± 2%, at 2 weeks for DG-N PEST Rabies SPLIT-TEVp-CRE and 8% ± 3%, at 2 weeks for DG Rabies p = 7x10 À3 , Figures  S3G-S3I ). However prominent neuronal loss was still present upon DG-N PEST Rabies SPLIT-TEVp-CRE infection (76% ± 3%, at 3 weeks, p = 9x10 À4 , Figures S3H-S3H 00 and S3I) .
The residual cytotoxicity of DG-N PEST Rabies SPLIT-TEVp-CRE might be linked to a constitutive low basal dimerization and activity of the SPLIT-TEVp cassette and can give origin to transcriptionally active viral particles. Consistent with this hypothesis, we observed no significant effect on neuronal survival and mCherry expression levels in presence or absence of rapamycin (mCherry expression 10 days p.i. DG-N PEST Rabies SPLIT-TEVp -RAP 87% ± 7%, DG-N PEST Rabies SPLIT-TEVp +RAP 85% ± 6%, p = 0.21; N = 3, n = 793 for each condition; paired two-tailed Student's t test; Figure S3E ) and no significant effects on cells survival were associated with the rapamycin administration in hESCs derived neurons (at 16 days; DG-Rabies +RAP 26% ± 4%, DG-Rabies -RAP 30% ± 7%, p = 0.69; DG-N PEST Rabies SPLIT-TEVp +RAP 88% ± 11%, DG-N PEST Rabies SPLIT-TEVp -RAP 94% ± 6%, p = 0.79; N = 3, n = 833 for each condition; paired two-tailed Student's t test, Figure S3D ). Furthermore, we observed a constitutive low level of TEVp activity in HEK293T cells in absence of Rapamycin ( Figure S2B, line 2) indicating a basal level of Rapamycin-independent SPLIT-TEVp dimerization. Overall these results indicate that DG-N PEST Rabies SPLIT-TEVp has reduced cytotoxicity in hESCs derived neurons and in vivo when compared to DG-Rabies. However, it fails to completely switch off following the infection, which leads to significantly delayed, yet still present, neuronal cytotoxicity and neuronal loss. For these reasons we generated a second generation of DG-N PEST Rabies by removing the leaking SPLIT-TEVp and replacing it with an mCherry-CRE cassette giving origin to a Self inactivating DG-Rabies virus (SiR) with the desired ON-OFF and TEVp dependent kinetics (main text).
Design and generation of DG-Rabies and lentivirus plasmids
All the attenuated Rabies plasmids, listed in Table S1 , were generated by Gibson cloning using pSAD-DG-F3 plasmid (Osakada et al., 2011) as starting material. Briefly, the Rabies genome was PCR amplified in 2 fragments starting from the protein to be tagged. These fragments were then mixed with the tag and/or PEST domain obtained by oligonucleotides annealing and assembled using Gibson master mix (NEB).
The lentiviral vectors used to generate the packaging cells were derived from a 3 rd generation lentivirus transfer vector (gift from Michael Hastings ''361 polylinker,'' originally pCCL-SIN-18PPT.Pgk.EGFP-WPRE). All the lentiviral vectors were generated by Gibson assembly, opening the backbone by digestion with XbaI and KpnI and PCR amplifying the CMV promoter and the different inserts.
Viral Screening and proteasome inhibition
For screening of attenuated DG-Rabies viruses, HEK-GG or HEK-TGG cells were co-transfected with rabies genome vector, pcDNA-T7, pcDNA-SADB19N, pcDNA-SADB19P, pcDNA-SADB19L, and pcDNA-SADB19G (Osakada et al., 2011) and maintained at 37 C with 5% CO 2 humidified atmosphere in DMEM supplemented with 10% FBS (GIBCO) and 100 u/ml Penicillin-Streptomycin. The day after transfection and subsequently every 3 days, cells were washed with PBS, treated with 0.05% trypsin-EDTA and replated in a new dish in a ratio 1:3. After splitting, cells were maintained for one day at 37 C and 5% CO 2 and then 2 days at 35 C and 3% CO 2 . Every 3 days cells were fixed with 4%PFA and viral spreading was assessed by FACS sorting the cells for mCherry expression.
For testing the proteasome dependence of attenuated DG-Rabies virus conditional inactivation, HEK-GG cells were co-transfected and processed as described before for the viral screening. At 3 days post transfection cells were treated with 10-100-250 nM of MG-132 (Sigma) or vehicle (0 nM condition, DMSO) in the medium until the end of the experiment. For the 250 nM MG-132 condition every 48 hr of incubation in DMEM supplemented with MG-132 cells were washed with PBS once and incubated in DMEM 10% FBS for 24 hr.
Viral productions
For the recovery of high titer DG-Rabies, HEK-GG or HEK-TGG for control or attenuated Rabies respectively, were infected in 10 cm dishes at 70%-80% confluence with 1 mL of viral supernatant obtained as described in the viral screening section. Cells were split the day after infection and maintained for 1 or 2 days at 37 C and 5% CO 2 checking daily the viral spreading. When 70%-80% of cells expressed the viral marker, the media was replaced with 2% FBS DMEM and maintained for 2 days at 35 C and 3% CO 2 . Then, the viral supernatant was collected, cell debris removed by centrifugation at 2500 rpm for 10 min followed by filtration with 0.45 mm filter and the virus concentrated by ultracentrifugation on a sucrose cushion as described before (Wickersham et al., 2007a) .
Rabies viruses pseudotyped with oG were produced infecting BHK-TGoG cells in 10 cm dishes with 1 mL of viral supernatant. Cells were split the day after infection and maintained for one or two days at 37 C and 5% CO 2 checking daily the viral spreading. When 70%-80% of cells expressed the viral marker, the media was replaced with 2% FBS DMEM and maintained for 2-3 days at 35 C and 3% CO 2 . Then, the supernatant was collected and processed as previously described.
Rabies viruses pseudotyped with EnvA were produced as previously described (Wickersham et al., 2007a) using BHK-T-EnvA cells instead of BHK-EnvA cells.
In vitro cytotoxicity analysis Human Embryonic Stem cells (hESCs) derived neurons were kindly provided by Dr. Rick Livesey. Cells were plated in 24-wells glass bottom plates and infected over-night with attenuated or control DG-Rabies viruses supernatants at comparable MOI to obtain $5% of infected cells. Cells were imaged every 4 days post infection overnight in a 37 C heated Leica SP8 confocal microscope in Hibernateâ-A Medium (Invitrogen) with 5 random fields imaged for each well. Cells survival was calculated normalizing each condition to the mortality of control Lentivirus GFP infected hESCs derived neurons imaged and processed in the same conditions.
Immunohistochemistry
Mice were perfused with ice cold phosphate buffered saline (PBS) followed by 4% paraformaldehyde (PFA) in PBS. Brains were incubated in PFA overnight at 4 C, rinsed twice with PBS and then dehydrated for 48 hr in 30% sucrose in PBS at 4 C. The brains were frozen in O.C.T. compound (VWR) and sliced at the cryostat (Leica, Germany). Free-floating sections were rinsed in PBS and then incubated in blocking solution (1% bovine serum albumin and 0.3% Triton X-100 in PBS) containing primary antibodies for 24 hr at 4 C. Sections were washed with PBS three times and incubated for 24 hr at 4 C in blocking solution with secondary antibodies. Immuno-labeled sections were washed three times with PBS and mounted on glass slides. Antibodies used in this study were chicken anti-GFP (Thermo Scientific, A10262, 1:1000), rabbit anti-RFP (Rockland, 600-401-379, 1:2000) , donkey anti-chicken alexa 488 (Jackson ImmunoResearch, 703-545-155, 1:1000), donkey anti-rabbit Cy3 (Jackson ImmunoResearch, 711-165-152, 1:1000) and rabbit anti-cleaved caspase-3 (NEB, #9661, 1:500).
Viral injections
All procedures using live animals were approved by the Home Office and the LMB Biosafety committee. For all experiments mice aged between 6-12 weeks were used. Mice were anesthetized with isofluorane delivered at a flow of 3% in 2L/min of oxygen for the initial induction and then maintained at 1%-2% in 2 L/min of oxygen. The anesthetized animal was placed into a stereotaxic apparatus (David Kopf Instruments) and Rimadyl (2 mg/kg body weight) was administered subcutaneously (s.c.) as anti-inflammatory. A small hole (500 mm diameter) was drilled and viruses were injected using a Hamilton neurosyringe. The syringe was left in the brain for 5 min before being retracted. Viruses were injected at the following titers: 3x10 8 infectious units/ml for Rabies viruses, 2x10 12 genomic copies/ml for AAVs, 3x10 8 infectious units/ml for Lentiviruses. Up to a max of 400 nL in volume of virus were injected in the following brain areas: CA1 (AP: À2.3 mm, ML: 1.65 mm and DV: 1.45mm from bregma), V1 (AP: À3.3 mm, ML: 2.8 mm and DV: 0.25 mm from brain surface), V2 (AP: À3.6 mm, ML: 1.2 mm, DV:0.6 mm from bregma), NAc (AP: 1.3 mm, ML: 1.3 mm and DV: 4.75 mm from bregma), VTA (AP: À3.2 mm, ML: 0.45 mm and DV: 4.35 mm from bregma), BLA (AP: À1.65 mm, ML: 2.9 mm and DV: 4.7 mm from bregma).
In vivo cytotoxicity analysis
To test the in vivo viral cytotoxicity, 400 nL of same titer (3x10 8 infectious units/ml) attenuated and control DG-Rabies were injected in CA1 area of the hippocampus in both hemispheres. At 1-2-3 weeks or 2-6 months p.i. brains were collected and sectioned at the cryostat (35 mm). Infected neurons were imaged sampling the entire hippocampus (acquiring one every 4 sections) using a robot assisted Nikon HCA microscope mounting a 10x (0.45NA) air objective and fluorescent hippocampal neurons counted using Nikon HCA analysis software. Cell survival for attenuated and control DG-Rabies was calculated normalizing each time point to the mortality of control Lentivirus-GFP infected hippocampi using the same injection protocol.
To confirm no cytotoxic effect upon SiR infection in hippocampus, brains slices at 1 and 2 weeks p.i. were stained with anti-cleaved caspase-3 (cCaspase3, 1:500). Confocal images were acquired using a Leica SP8 confocal microscope mounting a 20X (0.75NA) air objective and the total number of cCaspase3 positive neurons counted in PBS, SiR or DG-Rabies injected hippocampi.
Drug induced reactivation of SiR virus in vivo
Rosa-LoxP-STOP-LoxP-YFP animals were injected in CA1 of hippocampus with an AAV expressing constitutively rtTA and TEV protease under the control of a doxycycline inducible promoter (Table S1 ). 1-week p.i. the same area was re-injected with SiR CRE-mCherry and doxycycline (Santa Cruz Biotechnology, 100 mg/Kg) administered by oral gavage at 1 or 2 weeks post SiR injection. 1 week after drug administration brains were collected and sectioned at the cryostat (35 mm). Infected neurons were imaged and counted sampling the entire hippocampus (acquiring one every 4 sections) using a robot assisted Nikon HCA microscope.
Transsynaptic and intraneuronal retrograde tracing
To test the in vivo retrograde transsynaptic viral spreading efficiency, 400 nL of AAV TVA-oG were injected in the NAc contralateral in the 2 hemispheres of Rosa-LoxP-STOP-LoxP-tdTomato animals. At 3 weeks post-AAV injection, TVA expressing cells were targeted in the 2 hemispheres with 400 nL of same titer (3x10 8 infectious units/ml) SiR CRE or control DG-Rabies GFP . At 1 and 3 weeks p.i. brains were collected and sectioned at the cryostat (35 mm). Transsynaptic spreading and neuronal survival were assessed by imaging SiR or DG-Rabies infected neurons in the NAc, BLA and VTA (acquiring one every 2 sections) using a robot assisted Nikon HCA microscope mounting a 10x (0.45NA) air objective and ipsilateral fluorescent neurons counted using Nikon HCA analysis software. Transsynaptic spreading efficiency was calculated by dividing the number of inputs neurons in the BLA or VTA by the number of starting neurons and normalized to SiR efficiency.
To test the in vivo intraneuronal retrograde viral efficiency, 400 nL of SiR CRE (8.5x10 8 infectious units/ml) or 400 nL of rAAV2-retro-nucGFP (4x10 12 genomic copies/ml) were injected in the VTA of Rosa-LoxP-STOP-LoxP-tdTomato mice. the power at sample was controlled in the range 30-40 mW. Data analysis was performed in ImageJ and MATLAB and was restricted to cell bodies. Detection of region of interest (ROI) was performed with Suite2p (Pachitariu et al., 2016) . The relative changes in fluorescence were calculated as dF/F 0 = (F(t)-F 0 )/(F 0 ). Orientation tuning curves were generated by taking the mean response for each orientation during the entire stimulus period. Response amplitudes are presented as the relative change in fluorescence during the stimulus period compared to the pre-stimulus baseline (dF/F). All data are presented as mean ± SEM.
QUANTIFICATION AND STATISTICAL ANALYSIS
Mean values are accompanied by SEM. No statistical methods were used to predetermine sample sizes. Data collection and analysis were not performed blind to the conditions of the experiments. Statistical analysis was performed in R and/or MATLAB. Paired t test and one-way ANOVA test were used to test for statistical significance when appropriate. Statistical parameters including the exact value of n, precision measures (mean ± SEM) and statistical significance are reported in the text and in the figure legends (see individual sections). The significance threshold was placed at a = 0.05.
e7 Cell 170, 1-11.e1-e7, July 13, 2017 Percentage of DG-Rabies infected neurons at 1, 2 or 3 weeks p.i. in cortex (black) or hippocampus (gray) normalized to 1 week time-point (mean ± SEM,) (hippocampus, 92% ± 3% cell death at 2 weeks, n = 3 animals per time-point, one-way ANOVA, F = 101, p = 2.4x10 À5 ; cortex 85 % ± 2% cell death at 3 weeks, n = 3 animals per time-point, one-way ANOVA, F = 17, p = 3.2x10 À3 ). Confocal images of DG-Rabies GFP (D-E''') or SiR CRE (F-G''') infected hippocampi of Rosa-LoxP-STOP-LoxP-YFP mice at 1 and 2 weeks p.i. stained for cleaved caspase-3 (cCaspase3) (arrowheads point to DG-Rab-cCaspase3 double positive neurons). Scale bar: 25 mm (H) Percentage of positive cCaspase3 neurons every 1000 neurons at 1 and 2 weeks p.i. in PBS, DG-Rabies or SiR infected hippocampi (mean ± SEM, n = 3 animals per time-point). (C-E''') Two-photon maximal projection of V1 neurons 1, 2, or 4 months after SiR CRE injection. In cyan neurons expressing GCaMP6s (C, D, E), in magenta neurons expressing tdTomato (C', D', E') and in the merge neurons expressing both (C'', D'', E'' merge). Arrows and arrowheads highlight representative GCaMP6s (cyan) or GCaMP6s-tdTomato (magenta) expressing neurons respectively. Scale bar: 20 mm. (C''', D''', E''') Outline of the active ROIs from the same field of view showed in panel C, D and E. (F, G, H) Representative Ca 2+ traces of GCaMP6s (cyan) and GCaMP6s-tdTomato (magenta) neurons. Scale bars: 100 s, 20% dF/F 0 . (F', G', H') Mean percentage of active neurons after 1, 2 or 4 months from SiR injection (n = 241, 156, 231 respectively, mean ± SEM). (F'', G'', H'') Example of tuning curve of V1 infected neurons after 1, 2 or 4 months (GCaMP6s neurons (cyan) and GCaMP6s-tdTomato neurons (magenta); dF/F 0 mean ± SEM).
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